2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z

Wait List Removals and Transplant Rates Are Significantly Associated with Transplant Center Performance Oversight.

J. Schold, L. Buccini, E. Poggio, S. Flechner, D. Goldfarb.
Waitlist versus Population-Based Metrics of Access to Liver Transplantation: Comparing UNOS Waitlist Data and Nationally-Representative Data of Patients with End-Stage Liver Disease.

D. Goldberg,^1,2 B. French,² J. Lewis,^1,2 S. Halpern.^1,2
Watch Out for the Guy with the Low EPTS Score: Nonadherence and Kidney Allograft Failure.

A. Liu, K. Balabhadrapatruni, J. Augustine.
What Are the Benefits of Transvaginal Route for Kidney Extraction in Laparoscopic Living Donor Nephrectomy ?

S. Hurel,¹ M. Ariane,¹ F. Audenet,¹ C. Legendre,² A. Mejean,¹ M.-O. Timsit.¹
What Are the Charges and Costs of Transplanting High MELD Patients?

K. Bortecen, B. Gelb, A. Winnick, G. Morgan, L. Teperman.
What if Mycophenolic Acid Product Is Discontinued Less Than 6 Weeks Before Pregnancy?

N. Sifontis,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^2,4
What Is the Decline Rate of Pancreata Attributed to Donation After Cardiac Death When the Accompanied Kidney Is Transplanted?

T. Alhamad,¹ K. Lentine,² A. Taha,² J. Wellen,¹ D. Brennan.¹
What Living Organ Donors See as Their Unmet Needs in the United States.

S. Fry-Revere, M. Middelman.
When Liver Transplants and Procurement Occur at One Location – A National Study of Graft Survivals.

J. Ortiz,¹ N. Koizumi,² C. Kwon,² Y. Zhang,² C. Ortiz.³
When Living Donor Liver Allografts Fail: Exploring the Pitfalls of Retransplantation Using Deceased Donor Organs.

T. Bittermann,¹ A. Shaked,² K. Lloyd,² D. Goldberg.¹
Where Are the KDPI 0-20% Kidneys Going in the New KAS? A Major Allocation Shift.

M. Aeder,¹ N. Turgeon,² A. Kucheryavaya,³ D. Stewart.³
Which Is the Predictable Value of Post-Transplant HCC Recurrence Between Tumor-Related Factors at the Initial Diagnosis and the Transplantation?

J. Lee,^1,2 J. Lee,¹ J. Lee,³ S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ M. Ju,^1,2 M. Kim,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2
Which Is the Predictable Values of Post-Transplant Hepatocellular Carcinoma Recurrence in Patients Received Down Staging Therapy or Bridging Therapy?

S. Song, J. Lee, S.-K. Kwon, J. Lee, J. Lee, D. Han, G. Choi, M. Kim, J. Choi, S. Kim, D. Joo.
Which Post-Transplant Complications Are More Common in Elderly Renal Recipients?

F. Agena, F. Paula, B. Reichert, P. Neves, A. Piovesan, W. Nahas, E. David-Neto.
Who Should Decide? Potential Living Kidney Donor Preferences for Making Decisions About Risk.

C. Thiessen,¹ J. Gannon,¹ K. Kennedy,² D. Dobosz,¹ S. Li,¹ D. Gray,³ A. Mussell,³ E. Gordon,² P. Reese,³ S. Kulkarni.¹
Why Are Pancreas Transplants Declining in the United States in the Past Decade?

R. Stratta,¹ A. Gruessner,² J. Odorico,³ J. Fridell,⁴ J. Rogers,¹ A. Farney,¹ G. Orlando,¹ R. Gruessner.²
Why Do African American Patients Display Disparities in Renal Graft Function Following Renal Transplantation?

Y. Nyame, V. Gan, P. Aram, D. Greene, N. Yerram, C. Modlin, S. Flechner.
Widespread Weight Gain After Pancreas Transplantation May Worsen Metabolic Graft Function.

A. Gruessner, V. Whittaker, N. Ozden, R. Gruessner.
Will the New Kidney Allocation System Negatively Impact Future Organ Donation in States Mandated to Export a Large Number of Kidneys?

D. Mital,¹ E. Hull,¹ J. Brown,¹ C. Karmell,² M. Jendrisak.²
Would Transplanting Kidneys Currently Being Discarded in the US Place Programs at Risk for Regulatory Review?

J. Snyder, N. Salkowski, B. Thompson, A. Wey, A. Israni, B. Kasiske, S. Leppke.
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus.

P. Ueno,¹ H. Tedesco,¹ A. Brigido,¹ C. Felipe,¹ P. Hannun,¹ M. Cristelli,¹ W. Aguiar,² J. Medina-Pestana.¹

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z